Neurogene Inc (NGNE)

Cost of Revenue

$18.88M

TTM · Period ending: · USD

NGNE logo

NGNE Cost of Revenue

Latest reported$18.88M
NGNE TTM Cost of Revenue ($0.00 → $18.88M)
High-resolution chart · PNG

NGNE cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Neurogene Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
18,882,000
38,248,000
55,154,000
69,714,000
68,758,000
50,209,000
33,274,000
30,111,000
25,432,000
34,936,000
34,929,000
23,388,000
22,606,000
13,003,000
12,846,000
12,834,000
2,602,000
2,426,000
2,277,000
2,105,000
1,954,000
2,162,000
1,821,000
1,362,000
921,000
171,000
0
0
0
25,000,000
25,000,000
25,000,000
25,000,000
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.